Scientists have welcomed President Barack Obama’s recent decision to allow research on human embryonic stem cells. But in this week’s Scrubbing Up health column Dr Elizabeth Hill, who advises investors on how to sell new technologies, says pharmaceutical and biotech companies need to act now so that patients can benefit in the future.
Papildomos nuorodos
